Fresenius SE (FREd)

CBOE (Germany)Healthcare

€47.48
+€0.54 (+1.2%)
Last close

January 21, 2026 at 16:30 UTC

Interactive Chart
FREd
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Fresenius SE

Name

Fresenius SE

CEO

Michael Sen

Industry

Healthcare

Year Founded

1912

Employees

175,202

Fresenius SE is a healthcare company that combines manufacturing, services, and project expertise into a single operating approach. The group supports hospitals and care providers with medicines, clinical nutrition, devices, and technical services that fit routine practice. Business units work to a shared quality system, and documentation is written for regulators, payers, and clinical audit teams. Geographic reach spans mature health systems and emerging markets through regional subsidiaries that use the same core rules. Procurement and validation are handled as everyday disciplines rather than one-off campaigns. The company positions itself within the healthcare ecosystem as a partner that keeps therapies and services available while respecting clinical governance. Program cadence favors clear steps from evidence to labeling and from setup to steady care.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 5 Buy, 8 Hold, 11 Sell
Buy5
Hold8
Sell11
Fundamentals & Financials
Revenue (TTM)
€22.3B
Net Income (TTM)
€1.1B
EPS (TTM)
€2.03
ROA (TTM)
2.69%
Current Ratio
1.26
Dividend Yield
0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ3 2025
Revenue€5,485M
Cost of Sales€4,185M
Gross Profit€1,300M
Operating Income€465,000K
Net Income€344,000K
EPS€0.61
Technical Indicators

Fresenius SE's Technical Indicators Summary

FREd’s price action currently reflects a neutral stance, supported by modest trend strength as indicated by an ADX around 22, suggesting neither strong nor weak directional momentum. Momentum oscillators such as RSI and CCI remain in hold territory, while the MACD level is slightly positive but also neutral, reinforcing the lack of decisive momentum. The price trades below most short and medium-term moving averages, which signal bearish pressure, yet remains above longer-term averages that show some underlying support. Volatility is moderate with an ATR near 2%, and volume indicators like OBV hint at accumulation despite price softness. Meanwhile, the price sits just below the VWAP and key pivot points, which are currently bearish. Overall, the technical profile points to a market in balance without clear directional conviction.

Buy
5 signals
Neutral
8 signals
Sell
11 signals
Overall: Neutral33% Neutral signals
IndicatorValue
RSI (14)
42.67
Stochastic %K (14, 3, 3)
32.72
CCI (20)
-67.06
WPR (14)
-96.29
Momentum (10)
-0.87
MFI
56.35
MACD Level (12, 26)
0.41
Bollinger Bands
$46.49 - $51.54
ATR (14)
$1.06 (2.23%)
ADX (14)
22.09
OBV
47,902,343
VWAP
$48.09
Classic Pivot Point
$49.22
Fibonacci Pivot Point
$49.22
Simple Moving Averages
$45.12 - $49.83(5 indicators)
Exponential Moving Averages
$44.90 - $49.37(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

Into the close, FRE.DE retained a slight positive bias, with the 0.806% gap from yesterday leaving it near 47.50. By the end of trading, the sector had posted a modest gain of 1.10%, offering a gentle tailwind. FRE.DE's slight positive bias and the sector's modest gain offer a gentle tailwind amid limited headlines.

Price Change

from €47.12 close

+€0.38

Trading Volume

Below avg (918.2K)

445.4K

vs S&P 500 Today

Underperforming Market

-0.74%

52-Week Position

Upper range

78%

Updated: January 21, 2026 at 16:03 UTC

Quote Summary
OpenPrevious Close
€46.75€47.12
Day Range52 Week Range
€46.7 - €47.93€31.6 - €51.98
VolumeAvg. Volume
836.6K647.7K
Market CapP/E Ratio
€26.8B23.2